328 related articles for article (PubMed ID: 15828056)
21. Steroids excreted in urine by neonates with 21-hydroxylase deficiency. 3. Characterization, using GC-MS and GC-MS/MS, of androstanes and androstenes.
Christakoudi S; Cowan DA; Taylor NF
Steroids; 2012 Nov; 77(13):1487-501. PubMed ID: 22974828
[TBL] [Abstract][Full Text] [Related]
22. Steroidal isomers with uniform mass spectra of their per-TMS derivatives: synthesis of 17-hydroxyandrostan-3-ones, androst-1-, and -4-ene-3,17-diols.
Parr MK; Zapp J; Becker M; Opfermann G; Bartz U; Schänzer W
Steroids; 2007 Jun; 72(6-7):545-51. PubMed ID: 17509632
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone: Mass spectrometric identification of urinary metabolites.
Kohler M; Parr MK; Opfermann G; Thevis M; Schlörer N; Marner FJ; Schänzer W
Steroids; 2007 Mar; 72(3):278-86. PubMed ID: 17207827
[TBL] [Abstract][Full Text] [Related]
24. Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids.
Georgakopoulos CG; Vonaparti A; Stamou M; Kiousi P; Lyris E; Angelis YS; Tsoupras G; Wuest B; Nielen MW; Panderi I; Koupparis M
Rapid Commun Mass Spectrom; 2007; 21(15):2439-46. PubMed ID: 17610244
[TBL] [Abstract][Full Text] [Related]
25. Metabolic studies of oxyguno in horses.
Wong AS; Ho EN; Wan TS; Lam KK; Stewart BD
Anal Chim Acta; 2015 Sep; 891():190-202. PubMed ID: 26388378
[TBL] [Abstract][Full Text] [Related]
26. Determination of (13)C/(12)C ratios of endogenous urinary steroids excreted as sulpho conjugates.
Piper T; Opfermann G; Thevis M; Schänzer W
Rapid Commun Mass Spectrom; 2010 Nov; 24(21):3171-81. PubMed ID: 20941765
[TBL] [Abstract][Full Text] [Related]
27. [Studies on urinary metabolites of calusterone in man].
Zhang YZ; Liu X; Zhang CJ; Ye L
Yao Xue Xue Bao; 1993; 28(12):918-23. PubMed ID: 8030416
[TBL] [Abstract][Full Text] [Related]
28. Determination of 13C/12C ratios of endogenous urinary steroids: method validation, reference population and application to doping control purposes.
Piper T; Mareck U; Geyer H; Flenker U; Thevis M; Platen P; Schänzer W
Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2161-75. PubMed ID: 18536069
[TBL] [Abstract][Full Text] [Related]
29. Studies on the in vivo metabolism of methylstenbolone and detection of novel long term metabolites for doping control analysis.
Piper T; Fusshöller G; Schänzer W; Lagojda A; Kuehne D; Thevis M
Drug Test Anal; 2019 Nov; 11(11-12):1644-1655. PubMed ID: 31733090
[TBL] [Abstract][Full Text] [Related]
30. Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry.
Pozo OJ; Van Thuyne W; Deventer K; Van Eenoo P; Delbeke FT
J Mass Spectrom; 2008 Mar; 43(3):394-408. PubMed ID: 18035854
[TBL] [Abstract][Full Text] [Related]
31. Metabolic studies of 1-testosterone in horses.
Kwok WH; Ho EN; Leung GN; Tang FP; Wan TS; Wong HN; Yeung JH
Drug Test Anal; 2013 Feb; 5(2):81-8. PubMed ID: 22715048
[TBL] [Abstract][Full Text] [Related]
32. Detection of designer steroid methylstenbolone in "nutritional supplement" using gas chromatography and tandem mass spectrometry: elucidation of its urinary metabolites.
Cavalcanti Gde A; Leal FD; Garrido BC; Padilha MC; de Aquino Neto FR
Steroids; 2013 Feb; 78(2):228-33. PubMed ID: 23200734
[TBL] [Abstract][Full Text] [Related]
33. Tetrahydrogestrinone: discovery, synthesis, and detection in urine.
Catlin DH; Sekera MH; Ahrens BD; Starcevic B; Chang YC; Hatton CK
Rapid Commun Mass Spectrom; 2004; 18(12):1245-049. PubMed ID: 15174177
[TBL] [Abstract][Full Text] [Related]
34. Metabolic studies of mesterolone in horses.
Ho EN; Leung DK; Leung GN; Wan TS; Wong HN; Xu X; Yeung JH
Anal Chim Acta; 2007 Jul; 596(1):149-55. PubMed ID: 17616252
[TBL] [Abstract][Full Text] [Related]
35. Development of a sensitive GC-C-IRMS method for the analysis of androgens.
Polet M; Van Gansbeke W; Deventer K; Van Eenoo P
Biomed Chromatogr; 2013 Feb; 27(2):259-66. PubMed ID: 22815226
[TBL] [Abstract][Full Text] [Related]
36. Identification of the aromatase inhibitor aminoglutethimide in urine by gas chromatography/mass spectrometry.
Mareck U; Sigmund G; Opfermann G; Geyer H; Schänzer W
Rapid Commun Mass Spectrom; 2002; 16(24):2209-14. PubMed ID: 12478562
[TBL] [Abstract][Full Text] [Related]
37. Analysis of exogenous nandrolone metabolite in horse urine by gas chromatography/combustion/carbon isotope ratio mass spectrometry.
Yamada M; Kinoshita K; Kurosawa M; Saito K; Nakazawa H
J Pharm Biomed Anal; 2007 Nov; 45(4):654-8. PubMed ID: 17714906
[TBL] [Abstract][Full Text] [Related]
38. RSR13, a potential athletic performance enhancement agent: detection in urine by gas chromatography/mass spectrometry.
Breidbach A; Catlin DH
Rapid Commun Mass Spectrom; 2001; 15(24):2379-82. PubMed ID: 11746905
[TBL] [Abstract][Full Text] [Related]
39. New oxymesterone metabolites in human by gas chromatography-tandem mass spectrometry and their application for doping control.
Yang S; Lu J; Xu Y; Wang X
Drug Test Anal; 2016 Jul; 8(7):633-43. PubMed ID: 26197789
[TBL] [Abstract][Full Text] [Related]
40. Detection of sibutramine administration: a gas chromatography/mass spectrometry study of the main urinary metabolites.
Strano-Rossi S; Colamonici C; Botrè F
Rapid Commun Mass Spectrom; 2007; 21(2):79-88. PubMed ID: 17154357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
